Triethylenemelamine
![]()  | |
| Clinical data | |
|---|---|
| ATC code | 
  | 
| Identifiers | |
IUPAC name 
  | |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.076 | 
| Chemical and physical data | |
| Formula | C9H12N6 | 
| Molar mass | 204.237 g·mol−1 | 
| 3D model (JSmol) | |
SMILES 
  | |
InChI 
  | |
|   | |
Triethylenemelamine (abbreviated TEM, also called Tretamine) is a drug used in chemotherapy.[1]
It can cause chromatid aberrations in cell models.[2]
See also
References
- ↑ Wong JR, Morton LM, Tucker MA, Abramson DH, Seddon JM, Sampson JN, Kleinerman RA (October 2014). "Risk of subsequent malignant neoplasms in long-term hereditary retinoblastoma survivors after chemotherapy and radiotherapy". Journal of Clinical Oncology. 32 (29): 3284–3290. doi:10.1200/JCO.2013.54.7844. PMC 4178525. PMID 25185089.
 - ↑ Luippold HE, Gooch PC, Brewen JG (February 1978). "The production of chromosome aberrations in various mammalian cells by triethylenemelamine". Genetics. 88 (2): 317–326. doi:10.1093/genetics/88.2.317. PMC 1213803. PMID 565312.
 
    This article is issued from Wmcloud. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.
